Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies for cancer.
- Year invested 2016
- Investment Stage Seed
- Board Members
- Sectors
- Investment Status Current
- Website nkartatx.com/
- Company Status IPO/Public (NASDAQ: NKTX)